Hugel Inc (145020)

Currency in KRW
285,500
+6,000(+2.15%)
Delayed Data·
145020 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
277,000294,500
52 wk Range
208,500353,500
Key Statistics
Bid/Ask
285,000.00 / 286,000.00
Prev. Close
279,500
Open
277,000
Day's Range
277,000-294,500
52 wk Range
208,500-353,500
Volume
27.49K
Average Volume (3m)
55.55K
1-Year Change
-18.0516%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
145020 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
369,313
Upside
+29.36%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Hugel Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

15 Buy
1 Hold
0 Sell
Ratings:
16 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 369,313
(+29.36% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Macquarie
Buy320,000.00+12.08%310,000.00Maintain10-08-2026
Macquarie
Buy310,000.00+8.58%300,000.00Maintain07-07-2026
Macquarie
Buy340,000.00+19.09%320,000.00Maintain14-01-2026
Morgan Stanley
Hold324,000.00+13.49%375,000.00Maintain02-01-2026
Macquarie
Buy320,000.00+12.08%440,000.00Maintain06-11-2025

Earnings

Latest Release
06-08-2026
EPS / Forecast
3,018.81 / 3,024.80
Revenue / Forecast
137.9B / 127.64B
EPS Revisions
Last 90 days

145020 Income Statement

Compare 145020 to Peers and Sector

Metrics to compare
145020
Peers
Sector
Relationship
P/E Ratio
20.0x−18.5x−0.4x
PEG Ratio
2.75−0.180.00
Price/Book
3.0x2.3x2.6x
Price / LTM Sales
6.7x7.3x3.1x
Upside (Analyst Target)
33.6%25.8%48.2%
Fair Value Upside
Unlock16.9%5.8%Unlock

Hugel, Inc. develops and manufactures biopharmaceuticals in South Korea and internationally. The company offers Botulinum Toxin, a white injectable dry powder in a transparent glass vial for use in the treatment of positive essential eyelid convulsion in adults over 18 years of age; improvement of severe lasso wrinkles associated with corrugator muscles and/or procerus muscle activities in adults aged between 18 and 65; treatment of upper limb stroke; and treatment of dynamic equinus foot deformity in children with cerebral palsy over 2 years of age, as well as improvement of external angles of secondary ideals related to orbicularis oculi muscle activity in adults aged between 19 and 65 under the Botulax, Regenox, Zentox, Reage, Magnion, Hugel Toxin, Juvenlife, Botulim, and Botoshot brands. It also provides hyaluronic acid filler under the Dermalax, and The Chaeum brand names; cosmetics under the Wellage brand; and medical devices under BlueRose brand name. Hugel, Inc. was founded in 2001 and is headquartered in Chuncheon-si, South Korea.

Employees
594

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.32M21.49%634.90B
Other Institutional Investors
5.59M51.70%1.53T
Public Companies & Retail Investors
2.90M26.81%792.20B
Total
10.8M100.00%2.95T

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Aphrodite Acquisition Holdings LLC51.53%55,66,7911,52,25,17,339
Massachusetts Financial Services Company5.75%6,21,21616,99,02,576

FAQ

What Is the Hugel (145020) Share Price Today?

The Hugel share price today is 2,85,500.

What is the current Hugel (145020) share price and day range?

As of 11-08-2026, the Hugel share price is 2,85,500, with a previous close of 2,79,500. The share price has ranged from 2,77,000 to 2,94,500 today, while the 52-week range spans from 2,08,500 to 3,53,500.

What Is the Hugel Market Cap?

As of today, Hugel market cap is 3.02T.

What Is the Hugel (145020) Share Price Target?

The average 12-month share price target for Hugel is 3,69,313, with a high estimate of 430000 and a low estimate of 300000. 15 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +29.36% Upside potential.

What Is Hugel's Earnings Per Share (TTM)?

The Hugel EPS (TTM) is 13,992.

When Is the Next Hugel Earnings Date?

Hugel will release its next earnings report on 16-11-2026.

From a Technical Analysis Perspective, Is 145020 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

What Stock Exchange Does Hugel Trade On?

Hugel is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Hugel?

The stock symbol for Hugel is "145020."

How Many Times Has Hugel Stock Split?

Hugel has split 1 times.

How Many Employees Does Hugel Have?

Hugel has 594 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.